Search research articles
Contact Us
Filters
Showing results (151-160 of 182) with videos related to
Page
of 19
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex
Matthew C Eastwood, John Busby, David J Jackson, et al.
Chest
|
December 1, 2019
Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry
Eileen Wang, Michael E Wechsler, Trung N Tran, et al.
The Lancet. Respiratory Medicine
|
March 24, 2023
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial
Elaine Mac Hale, Garrett Greene, Christopher Mulvey, et al.
ERJ Open Research
|
February 10, 2021
The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?
Steven J Smith, John Busby, Liam G Heaney, et al.
Pragmatic and Observational Research
|
August 19, 2021
Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients
Rupert Jones, Andrew Davis, Brooklyn Stanley, et al.
The Lancet. Respiratory Medicine
|
April 11, 2025
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials
Fleur L Meulmeester, Samuel Mailhot-Larouche, Carlos Celis-Preciado, et al.
The Journal of Allergy and Clinical Immunology
|
June 14, 2023
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control
Xue Zeng, Jing Qing, Chi-Ming Li, et al.
The Lancet. Respiratory Medicine
|
May 29, 2026
Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study
Jennifer Logan, Kirsty Martin, Lynsey Gillespie, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 29, 2014
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo
David J Jackson, Heidi Makrinioti, Batika M J Rana, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 18, 2024
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study
Ratko Djukanović, Paul Brinkman, Johan Kolmert, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 182) with videos related to
Sort By:
Page
of 19
The Journal of Allergy and Clinical Immunology. in Practice
|
January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex
Matthew C Eastwood, John Busby, David J Jackson, et al.
Chest
|
December 1, 2019
Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry
Eileen Wang, Michael E Wechsler, Trung N Tran, et al.
The Lancet. Respiratory Medicine
|
March 24, 2023
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial
Elaine Mac Hale, Garrett Greene, Christopher Mulvey, et al.
ERJ Open Research
|
February 10, 2021
The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?
Steven J Smith, John Busby, Liam G Heaney, et al.
Pragmatic and Observational Research
|
August 19, 2021
Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients
Rupert Jones, Andrew Davis, Brooklyn Stanley, et al.
The Lancet. Respiratory Medicine
|
April 11, 2025
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials
Fleur L Meulmeester, Samuel Mailhot-Larouche, Carlos Celis-Preciado, et al.
The Journal of Allergy and Clinical Immunology
|
June 14, 2023
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control
Xue Zeng, Jing Qing, Chi-Ming Li, et al.
The Lancet. Respiratory Medicine
|
May 29, 2026
Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study
Jennifer Logan, Kirsty Martin, Lynsey Gillespie, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 29, 2014
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo
David J Jackson, Heidi Makrinioti, Batika M J Rana, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 18, 2024
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study
Ratko Djukanović, Paul Brinkman, Johan Kolmert, et al.
Page
of 19